Previous 10 | Next 10 |
Biotres is designed to continuously record ECG data for early detection of cardiac arrhythmias The Biotres addresses the $2 Billion -dollar holter market REDWOOD CITY, CA / ACCESSWIRE / January 24, 2022 / Biotricity, Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a ...
Biotricity (BTCY -2.3%) announced that its new Bioheart heart monitor system is now available on the e-commerce platform, Amazon.com. Bioheart is a direct-to-consumer device designed to offer continuous heart monitoring technology. The company has expanded the commercial reach of Bioheart on ...
New Heart Monitoring Solution Delivers Personalized Heart Health Insights Directly to Your Smartphone Now Easy to Buy and Use: No Prescription Needed for Advanced Heart and Lifestyle Solution REDWOOD CITY, CA / ACCESSWIRE / December 28, 2021 / Biotricity Inc. (NASDAQ:BTCY) a mode...
Biotricity (BTCY +7.3%) is trading higher after the company announced the completion of a $12M non-convertible debt financing provided by SWK Funding LLC (NASDAQ:SWKH). Per the contractual terms, the health tech company will have an initial interest-only period of two years extendable to thre...
Capital infusion to finance inventory and annual recurring revenue subscriptions replaces expiring debt with more favorable terms 5-year term deal strengthens balance sheet, positions company for multiple new product launches in 2022 REDWOOD CITY, CA / ACCESSWIRE / December 27, 202...
The Company believes that it is "well-positioned for 2022." Letter highlights milestones, products roadmap, growth strategy and 2022 goals REDWOOD CITY, CA / ACCESSWIRE / December 7, 2021 / Biotricity, Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and c...
Continuous monitoring device with advanced features and analytics to deliver personalized insights directly to the smartphone Biotricity , Inc. (NASDAQ:BTCY), a modern medical technology company focused on delivering innovative, remote biometric monitoring soluti...
Biotricity Inc. (BTCY) Q2 2022 Earnings Conference Call November 4, 2021 5:00 PM ET Company Participants Mark Forney – MKR Investor Relations Waqaas Al-Siddiq – Founder and Chief Executive Officer John Ayanoglou – Chief Financial Officer Conference Call Participants Allen...
Biotricity (NASDAQ:BTCY): Q2 Non-GAAP EPS of -$0.13 misses by $0.02; GAAP EPS of -$0.26 misses by $0.07. Revenue of $1.81M misses by $0.1M. Press Release For further details see: Biotricity EPS misses by $0.02, misses on revenue
Company reports tenth consecutive quarter of triple-digit year-over-year revenue growth Strongest balance sheet since inception REDWOOD CITY, CA / ACCESSWIRE / November 4, 2021 / Biotricity Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, tod...
News, Short Squeeze, Breakout and More Instantly...
REDWOOD CITY, CA / ACCESSWIRE / July 22, 2024 / Biotricity Inc. (Nasdaq:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced ongoing improvements in operational efficiency, scalability and margin performance driven...
ORLANDO, FL / ACCESSWIRE / July 19, 2024 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and Biotricity, Inc. (Nasdaq:BTCY) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 20, at 7 p.m. Eastern T...
ORLANDO, FL / ACCESSWIRE / July 12, 2024 / RedChip Companies will air interviews with Biotricity, Inc. (Nasdaq:BTCY) and bioAffinity Technologies, Inc. (Nasdaq:BIAF) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 13, at 7 p.m. East...